We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Agilent Appoints Ambry Genetics as First CSP for Agilent’s Target Enrichment System for Next-Gen Sequencing

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute
Agilent Technologies Inc. and Ambry Genetics have announced that Ambry is the first organization to achieve Certified Service Provider (CSP) status for Agilent’s SureSelect Target Enrichment System for next-generation sequencing.

SureSelect, introduced in February 2009, has been shown to increase the speed of next-generation sequencing workflows used in life science research by enabling experiments to focus on genomic regions of interest rather than sequencing the entire genome.

Ambry was awarded CSP status for the SureSelect Target Enrichment System after demonstrating a high level of proficiency using the system with the Illumina Genome Analyzer.

“It’s gratifying that a high-quality organization like Ambry is now offering SureSelect to its customers supported by the excellent skills and expertise of their people,” said Fred Ernani, Ph.D., Agilent senior product manager for Emerging Genomics Applications. “This is Agilent’s flagship target-enrichment product, and Ambry is well-suited for acquainting the genomics community with the efficiencies of SureSelect.”

“We at Ambry Genetics continue to invest in cutting-edge next-generation sequencing technologies to help researchers advance their genomic projects,” said Ardy Arianpour, director of Business Development, Pharmaceutical Services at Ambry Genetics. “Ambry Genetics is a leader in next-generation sequencing services, and the addition of Agilent’s flagship SureSelect System strengthens our sequence-capture capabilities and allows us to expand our prime portfolio for genomics.”

The Agilent SureSelect Target Enrichment System is based on an in-solution design, making it automation-friendly and scalable from 10 reactions through thousands.

“At Ambry, we use sequence-capture technologies as an efficient and economical approach for targeted sequencing projects on the Illumina GAIIx,” said Phillip Gray, Ph.D., Ambry’s lead scientist for next-generation sequencing projects. “Agilent’s SureSelect Target Enrichment System is a great option for researchers who want to perform sequence capture in solution. The technology platform is flexible and allows researchers to design custom capture libraries using Agilent’s eArray software.”

Users can design their own custom SureSelect kits using Agilent’s eArray online design tool, which contains many key genomes and also lets users upload their own sequences. Because sample requirement is 3 micrograms or less of gDNA, researchers can perform highly targeted next-generation sequencing on precious samples.